Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: J Pharmacol Exp Ther. 2008 Apr 16;326(1):196–208. doi: 10.1124/jpet.108.137455

Fig. 1.

Fig. 1

Schematic paradigms of curcumin and TC treatments. A, mice were treated with Curc or TC by gav, i.p., or i.m. using doses of 0.4, 0.4, or 0.2 µmol (148, 148, or 73.4 µg), respectively. B, aged Tg2576 APPsw transgenic mice were fed diets ad libitum with or without curcumin and TC for 4 months at 500 ppm (500 mg/kg chow).